A 0 1 0 1 O
maximum 2 9 2 9 O
of 10 12 10 12 O
1/3 13 16 13 16 B-lower_bound
of 17 19 17 19 O
patients 20 28 20 28 O
in 29 31 29 31 O
cohorts 32 39 32 39 O
A 40 41 40 41 O
& 42 43 42 43 O
B 44 45 44 45 O
may 46 49 46 49 O
be 50 52 50 52 O
WHO 53 56 53 56 O
performance 57 68 57 68 O
status 69 75 69 75 O
2 76 77 76 77 O

Active 0 6 78 84 O
or 7 9 85 87 O
clinically 10 20 88 98 O
significant 21 32 99 110 O
cardiac 33 40 111 118 O
disease 41 48 119 126 O
including 49 58 127 136 O
: 58 59 136 137 O
Congestive 60 70 138 148 B-chronic_disease
heart 71 76 149 154 I-chronic_disease
failure 77 84 155 162 I-chronic_disease
- 84 85 162 163 O
New 85 88 163 166 B-clinical_variable
York 89 93 167 171 I-clinical_variable
Heart 94 99 172 177 I-clinical_variable
Association 100 111 178 189 I-clinical_variable
( 112 113 190 191 I-clinical_variable
NYHA 113 117 191 195 I-clinical_variable
) 117 118 195 196 I-clinical_variable
> 119 120 197 198 O
class 121 126 199 204 B-lower_bound
II 127 129 205 207 I-lower_bound
, 129 130 207 208 O
Active 131 137 209 215 O
coronary 138 146 216 224 B-chronic_disease
artery 147 153 225 231 I-chronic_disease
disease 154 161 232 239 I-chronic_disease
, 161 162 239 240 O
Cardiac 163 170 241 248 O
arrhythmias 171 182 249 260 B-chronic_disease
requiring 183 192 261 270 O
anti 193 197 271 275 B-treatment
- 197 198 275 276 I-treatment
arrhythmic 198 208 276 286 I-treatment
therapy 209 216 287 294 I-treatment
other 217 222 295 300 O
than 223 227 301 305 O
beta 228 232 306 310 B-treatment
blockers 233 241 311 319 I-treatment
or 242 244 320 322 O
digoxin 245 252 323 330 B-treatment
, 252 253 330 331 O
Unstable 254 262 332 340 B-chronic_disease
angina 263 269 341 347 I-chronic_disease
( 270 271 348 349 O
anginal 271 278 349 356 O
symptoms 279 287 357 365 O
at 288 290 366 368 O
rest 291 295 369 373 O
) 295 296 373 374 O
, 296 297 374 375 O
new 298 301 376 379 O
onset 302 307 380 385 O
angina 308 314 386 392 O
within 315 321 393 399 O
3 322 323 400 401 B-upper_bound
months 324 330 402 408 I-upper_bound
before 331 337 409 415 O
randomization 338 351 416 429 O
, 351 352 429 430 O
or 353 355 431 433 O
myocardial 356 366 434 444 B-chronic_disease
infarction 367 377 445 455 I-chronic_disease
within 378 384 456 462 O
6 385 386 463 464 B-upper_bound
months 387 393 465 471 I-upper_bound
before 394 400 472 478 O
randomization 401 414 479 492 O

Adequate 0 8 493 501 O
organ 9 14 502 507 O
function 15 23 508 516 O
within 24 30 517 523 O
14 31 33 524 526 B-upper_bound
days 34 38 527 531 I-upper_bound
of 39 41 532 534 O
registration 42 54 535 547 O

Age 0 3 548 551 B-age
≥ 4 5 552 553 O
10 6 8 554 556 B-lower_bound
year 9 13 557 561 I-lower_bound
for 14 17 562 565 O
Liposarcoma 18 29 566 577 B-cancer
, 29 30 577 578 O
Osteosarcoma 31 43 579 591 B-cancer
, 43 44 591 592 O
and 45 48 593 596 O
Ewing 49 54 597 602 B-cancer
sarcoma 55 62 603 610 I-cancer

Age 0 3 611 614 B-age
≥ 4 5 615 616 O
5 6 7 617 618 B-lower_bound
years 8 13 619 624 I-lower_bound
for 14 17 625 628 O
Rhabdomyosarcoma 18 34 629 645 B-cancer
cohorts 35 42 646 653 O

All 0 3 654 657 O
acute 4 9 658 663 O
toxic 10 15 664 669 O
effects 16 23 670 677 O
of 24 26 678 680 O
any 27 30 681 684 O
prior 31 36 685 690 B-treatment
treatment 37 46 691 700 I-treatment
have 47 51 701 705 O
resolved 52 60 706 714 O
to 61 63 715 717 O
NCI 64 67 718 721 O
- 67 68 721 722 O
CTCAE 68 73 722 727 B-clinical_variable
v 74 75 728 729 I-clinical_variable
4.0 76 79 730 733 I-clinical_variable
Grade 80 85 734 739 I-clinical_variable
1 86 87 740 741 B-upper_bound
or 88 90 742 744 O
less 91 95 745 749 O
( 96 97 750 751 O
except 97 103 751 757 O
alopecia 104 112 758 766 B-chronic_disease
) 112 113 766 767 O
at 114 116 768 770 O
the 117 120 771 774 O
time 121 125 775 779 O
of 126 128 780 782 O
signing 129 136 783 790 O
the 137 140 791 794 O
Informed 141 149 795 803 O
Consent 150 157 804 811 O
Form 158 162 812 816 O
( 163 164 817 818 O
ICF 164 167 818 821 O
) 167 168 821 822 O

Any 0 3 823 826 O
hemorrhage 4 14 827 837 B-chronic_disease
or 15 17 838 840 O
bleeding 18 26 841 849 O
event 27 32 850 855 O
≥ 33 34 856 857 O
NCI 35 38 858 861 B-clinical_variable
CTCAE 39 44 862 867 I-clinical_variable
Grade 45 50 868 873 B-lower_bound
3 51 52 874 875 I-lower_bound
within 53 59 876 882 O
4 60 61 883 884 B-upper_bound
weeks 62 67 885 890 I-upper_bound
prior 68 73 891 896 I-upper_bound
to 74 76 897 899 O
study 77 82 900 905 O
registration 83 95 906 918 O

Any 0 3 919 922 O
malabsorption 4 17 923 936 B-chronic_disease
condition 18 27 937 946 O

At 0 2 947 949 O
least 3 8 950 955 O
one 9 12 956 959 B-lower_bound
prior 13 18 960 965 B-treatment
line 19 23 966 970 I-treatment
of 24 26 971 973 I-treatment
systemic 27 35 974 982 I-treatment
therapy 36 43 983 990 I-treatment
for 44 47 991 994 O
the 48 51 995 998 O
sarcoma 52 59 999 1006 B-cancer
diagnosis 60 69 1007 1016 O
( 70 71 1017 1018 O
neoadjuvant 71 82 1018 1029 B-treatment
, 82 83 1029 1030 O
adjuvant 84 92 1031 1039 O
or 93 95 1040 1042 O
metastatic 96 106 1043 1053 O
disease 107 114 1054 1061 O
) 114 115 1061 1062 O

At 0 2 1063 1065 O
least 3 8 1066 1071 O
one 9 12 1072 1075 B-lower_bound
site 13 17 1076 1080 O
of 18 20 1081 1083 O
measurable 21 31 1084 1094 O
disease 32 39 1095 1102 O
on 40 42 1103 1105 O
x 43 44 1106 1107 B-treatment
- 44 45 1107 1108 I-treatment
ray 45 48 1108 1111 I-treatment
/ 48 49 1111 1112 O
CT 49 51 1112 1114 B-treatment
/ 51 52 1114 1115 O
MRI 52 55 1115 1118 B-treatment
scan 56 60 1119 1123 I-treatment
as 61 63 1124 1126 O
defined 64 71 1127 1134 O
by 72 74 1135 1137 O
RECIST 75 81 1138 1144 O

Concurrent 0 10 1145 1155 O
, 10 11 1155 1156 O
clinically 12 22 1157 1167 O
significant 23 34 1168 1179 O
, 34 35 1179 1180 O
active 36 42 1181 1187 O
malignancies 43 55 1188 1200 B-cancer
within 56 62 1201 1207 O
12 63 65 1208 1210 B-upper_bound
months 66 72 1211 1217 I-upper_bound
of 73 75 1218 1220 O
study 76 81 1221 1226 O
enrollment 82 92 1227 1237 O

Evidence 0 8 1238 1246 O
or 9 11 1247 1249 O
history 12 19 1250 1257 O
of 20 22 1258 1260 O
bleeding 23 31 1261 1269 B-chronic_disease
diathesis 32 41 1270 1279 I-chronic_disease

History 0 7 1280 1287 O
of 8 10 1288 1290 O
organ 11 16 1291 1296 O
allograft 17 26 1297 1306 O
( 27 28 1307 1308 O
including 28 37 1308 1317 O
corneal 38 45 1318 1325 B-treatment
transplant 46 56 1326 1336 I-treatment
) 56 57 1336 1337 O

Interstitial 0 12 1338 1350 B-chronic_disease
lung 13 17 1351 1355 I-chronic_disease
disease 18 25 1356 1363 I-chronic_disease
with 26 30 1364 1368 O
ongoing 31 38 1369 1376 O
signs 39 44 1377 1382 O
and 45 48 1383 1386 O
symptoms 49 57 1387 1395 O
at 58 60 1396 1398 O
the 61 64 1399 1402 O
time 65 69 1403 1407 O
of 70 72 1408 1410 O
informed 73 81 1411 1419 O
consent 82 89 1420 1427 O

Known 0 5 1428 1433 O
history 6 13 1434 1441 O
of 14 16 1442 1444 O
human 17 22 1445 1450 B-chronic_disease
immunodeficiency 23 39 1451 1467 I-chronic_disease
virus 40 45 1468 1473 I-chronic_disease
( 46 47 1474 1475 I-chronic_disease
HIV 47 50 1475 1478 I-chronic_disease
) 50 51 1478 1479 I-chronic_disease
infection 52 61 1480 1489 I-chronic_disease
or 62 64 1490 1492 O
current 65 72 1493 1500 O
chronic 73 80 1501 1508 O
or 81 83 1509 1511 O
active 84 90 1512 1518 O
hepatitis 91 100 1519 1528 B-chronic_disease
B 101 102 1529 1530 I-chronic_disease
or 103 105 1531 1533 I-chronic_disease
C 106 107 1534 1535 I-chronic_disease
infection 108 117 1536 1545 I-chronic_disease
requiring 118 127 1546 1555 O
treatment 128 137 1556 1565 B-treatment
with 138 142 1566 1570 O
antiviral 143 152 1571 1580 B-treatment
therapy 153 160 1581 1588 I-treatment

Known 0 5 1589 1594 O
or 6 8 1595 1597 O
suspected 9 18 1598 1607 O
allergy 19 26 1608 1615 O
or 27 29 1616 1618 O
hypersensitivity 30 46 1619 1635 O
to 47 49 1636 1638 O
regorafenib 50 61 1639 1650 B-allergy_name
, 61 62 1650 1651 O
or 63 65 1652 1654 O
excipients 66 76 1655 1665 O
of 77 79 1666 1668 O
the 80 83 1669 1672 O
formulations 84 96 1673 1685 O
given 97 102 1686 1691 O
during 103 109 1692 1698 O
the 110 113 1699 1702 O
course 114 120 1703 1709 O
of 121 123 1710 1712 O
this 124 128 1713 1717 O
trial 129 134 1718 1723 O

Major 0 5 1724 1729 B-treatment
surgery 6 13 1730 1737 I-treatment
within 14 20 1738 1744 O
28 21 23 1745 1747 B-upper_bound
days 24 28 1748 1752 I-upper_bound
prior 29 34 1753 1758 I-upper_bound
to 35 37 1759 1761 O
study 38 43 1762 1767 O
registration 44 56 1768 1780 O
or 57 59 1781 1783 O
those 60 65 1784 1789 O
patients 66 74 1790 1798 O
who 75 78 1799 1802 O
have 79 83 1803 1807 O
not 84 87 1808 1811 O
recovered 88 97 1812 1821 O
adequately 98 108 1822 1832 O
from 109 113 1833 1837 O
prior 114 119 1838 1843 O
surgery 120 127 1844 1851 O

Ongoing 0 7 1852 1859 B-clinical_variable
infection 8 17 1860 1869 I-clinical_variable
> 18 19 1870 1871 O
Grade 20 25 1872 1877 B-lower_bound
2 26 27 1878 1879 I-lower_bound
NCI 28 31 1880 1883 B-clinical_variable
- 31 32 1883 1884 I-clinical_variable
CTCAE 32 37 1884 1889 I-clinical_variable
v 38 39 1890 1891 O
4.03 40 44 1892 1896 O

Patients 0 8 1897 1905 O
must 9 13 1906 1910 O
have 14 18 1911 1915 O
histologically 19 33 1916 1930 O
or 34 36 1931 1933 O
cytologically 37 50 1934 1947 O
confirmed 51 60 1948 1957 O
advanced 61 69 1958 1966 O
/ 69 70 1966 1967 O
metastatic 70 80 1967 1977 O
liposarcoma 81 92 1978 1989 B-cancer
, 92 93 1989 1990 O
osteogenic 94 104 1991 2001 B-chronic_disease
sarcoma 105 112 2002 2009 I-chronic_disease
, 112 113 2009 2010 O
Ewing 114 119 2011 2016 B-cancer
/ 119 120 2016 2017 O
Ewing 120 125 2017 2022 B-cancer
- 125 126 2022 2023 I-cancer
like 126 130 2023 2027 I-cancer
sarcoma 131 138 2028 2035 I-cancer
of 139 141 2036 2038 O
soft 142 146 2039 2043 O
tissue 147 153 2044 2050 O
or 154 156 2051 2053 O
bone 157 161 2054 2058 O
, 161 162 2058 2059 O
fusion 163 169 2060 2066 O
- 169 170 2066 2067 O
positive 170 178 2067 2075 O
alveolar 179 187 2076 2084 B-cancer
rhabdomyosarcoma 188 204 2085 2101 I-cancer
or 205 207 2102 2104 O
embryonal 208 217 2105 2114 B-cancer
rhabdomyosarcoma 218 234 2115 2131 I-cancer
/ 234 235 2131 2132 O
fusion 235 241 2132 2138 O
- 241 242 2138 2139 O
negative 242 250 2139 2147 O
alveolar 251 259 2148 2156 O
rhabdomyosarcoma 260 276 2157 2173 O

Patients 0 8 2174 2182 O
who 9 12 2183 2186 O
have 13 17 2187 2191 O
received 18 26 2192 2200 O
prior 27 32 2201 2206 B-treatment
systemic 33 41 2207 2215 I-treatment
therapy 42 49 2216 2223 I-treatment
< 50 51 2224 2225 O
14 52 54 2226 2228 B-upper_bound
days 55 59 2229 2233 I-upper_bound
prior 60 65 2234 2239 I-upper_bound
to 66 68 2240 2242 O
study 69 74 2243 2248 O
registration 75 87 2249 2261 O
or 88 90 2262 2264 O
have 91 95 2265 2269 O
not 96 99 2270 2273 O
recovered 100 109 2274 2283 O
adequately 110 120 2284 2294 O
from 121 125 2295 2299 O
toxicities 126 136 2300 2310 O
to 137 139 2311 2313 O
CTCAE 140 145 2314 2319 B-clinical_variable
v. 146 148 2320 2322 O
4.03 149 153 2323 2327 O
grade 154 159 2328 2333 B-upper_bound
1 160 161 2334 2335 I-upper_bound
or 162 164 2336 2338 O
less 165 169 2339 2343 O

Patients 0 8 2344 2352 O
who 9 12 2353 2356 O
have 13 17 2357 2361 O
received 18 26 2362 2370 O
wide 27 31 2371 2375 O
field 32 37 2376 2381 O
radiotherapy 38 50 2382 2394 B-treatment
≤ 51 52 2395 2396 O
28 53 55 2397 2399 B-upper_bound
days 56 60 2400 2404 I-upper_bound
( 61 62 2405 2406 O
defined 62 69 2406 2413 O
as 70 72 2414 2416 O
> 73 74 2417 2418 O
50 75 77 2419 2421 B-lower_bound
% 77 78 2421 2422 I-lower_bound
of 79 81 2423 2425 O
volume 82 88 2426 2432 B-clinical_variable
of 89 91 2433 2435 I-clinical_variable
pelvis 92 98 2436 2442 I-clinical_variable
bones 99 104 2443 2448 I-clinical_variable
or 105 107 2449 2451 O
equivalent 108 118 2452 2462 O
) 118 119 2462 2463 O
or 120 122 2464 2466 O
limited 123 130 2467 2474 O
field 131 136 2475 2480 O
radiation 137 146 2481 2490 B-treatment
for 147 150 2491 2494 I-treatment
palliation 151 161 2495 2505 I-treatment
< 162 163 2506 2507 O
14 164 166 2508 2510 B-upper_bound
days 167 171 2511 2515 I-upper_bound
prior 172 177 2516 2521 I-upper_bound
to 178 180 2522 2524 O
study 181 186 2525 2530 O
registration 187 199 2531 2543 O
or 200 202 2544 2546 O
those 203 208 2547 2552 O
patients 209 217 2553 2561 O
who 218 221 2562 2565 O
have 222 226 2566 2570 O
not 227 230 2571 2574 O
recovered 231 240 2575 2584 O
adequately 241 251 2585 2595 O
from 252 256 2596 2600 O
side 257 261 2601 2605 O
effects 262 269 2606 2613 O
of 270 272 2614 2616 O
such 273 277 2617 2621 O
therapy 278 285 2622 2629 O

Patients 0 8 2630 2638 O
who 9 12 2639 2642 O
progress 13 21 2643 2651 O
on 22 24 2652 2654 O
placebo 25 32 2655 2662 O
are 33 36 2663 2666 O
specifically 37 49 2667 2679 O
allowed 50 57 2680 2687 O
to 58 60 2688 2690 O
enroll 61 67 2691 2697 O
on 68 70 2698 2700 O
the 71 74 2701 2704 O
treatment 75 84 2705 2714 B-treatment
arm 85 88 2715 2718 O
of 89 91 2719 2721 O
the 92 95 2722 2725 O
study 96 101 2726 2731 O
if 102 104 2732 2734 O
they 105 109 2735 2739 O
meet 110 114 2740 2744 O
all 115 118 2745 2748 O
other 119 124 2749 2754 O
entry 125 130 2755 2760 O
criteria 131 139 2761 2769 O

Patients 0 8 2770 2778 O
with 9 13 2779 2783 O
central 14 21 2784 2791 B-chronic_disease
nervous 22 29 2792 2799 I-chronic_disease
system 30 36 2800 2806 I-chronic_disease
disease 37 44 2807 2814 I-chronic_disease
are 45 48 2815 2818 O
eligible 49 57 2819 2827 O
for 58 61 2828 2831 O
enrollment 62 72 2832 2842 O
if 73 75 2843 2845 O
they 76 80 2846 2850 O
have 81 85 2851 2855 O
received 86 94 2856 2864 O
prior 95 100 2865 2870 B-treatment
radiotherapy 101 113 2871 2883 I-treatment
or 114 116 2884 2886 O
surgery 117 124 2887 2894 B-treatment
to 125 127 2895 2897 O
sites 128 133 2898 2903 O
of 134 136 2904 2906 O
CNS 137 140 2907 2910 B-cancer
( 141 142 2911 2912 I-cancer
central 142 149 2912 2919 I-cancer
nervous 150 157 2920 2927 I-cancer
system 158 164 2928 2934 I-cancer
) 164 165 2934 2935 I-cancer
metastatic 166 176 2936 2946 I-cancer
disease 177 184 2947 2954 I-cancer
and 185 188 2955 2958 O
are 189 192 2959 2962 O
without 193 200 2963 2970 O
evidence 201 209 2971 2979 O
of 210 212 2980 2982 O
clinical 213 221 2983 2991 O
progression 222 233 2992 3003 O
for 234 237 3004 3007 O
at 238 240 3008 3010 O
least 241 246 3011 3016 O
12 247 249 3017 3019 B-lower_bound
weeks 250 255 3020 3025 I-lower_bound
after 256 261 3026 3031 I-lower_bound
therapy 262 269 3032 3039 O

Patients 0 8 3040 3048 O
with 9 13 3049 3053 O
documentation 14 27 3054 3067 O
of 28 30 3068 3070 O
well 31 35 3071 3075 O
differentiated 36 50 3076 3090 O
liposarcoma 51 62 3091 3102 B-cancer
only 63 67 3103 3107 O
( 68 69 3108 3109 O
of 69 71 3109 3111 O
the 72 75 3112 3115 O
well 76 80 3116 3120 O
differentiated 81 95 3121 3135 O
/ 95 96 3135 3136 O
dedifferentiated 96 112 3136 3152 O
liposarcoma 113 124 3153 3164 O
family 125 131 3165 3171 O
) 131 132 3171 3172 O
are 133 136 3173 3176 O
specifically 137 149 3177 3189 O
excluded 150 158 3190 3198 O
, 158 159 3198 3199 O
owing 160 165 3200 3205 O
to 166 168 3206 3208 O
its 169 172 3209 3212 O
characteristically 173 191 3213 3231 O
slow 192 196 3232 3236 O
growth 197 203 3237 3243 O

Patients 0 8 3244 3252 O
with 9 13 3253 3257 O
seizure 14 21 3258 3265 B-chronic_disease
disorder 22 30 3266 3274 I-chronic_disease
requiring 31 40 3275 3284 O
medication 41 51 3285 3295 B-treatment

Pleural 0 7 3296 3303 B-chronic_disease
effusion 8 16 3304 3312 I-chronic_disease
or 17 19 3313 3315 O
ascites 20 27 3316 3323 B-chronic_disease
that 28 32 3324 3328 O
causes 33 39 3329 3335 O
respiratory 40 51 3336 3347 O
compromise 52 62 3348 3358 O

Presence 0 8 3359 3367 O
of 9 11 3368 3370 O
a 12 13 3371 3372 O
non 14 17 3373 3376 O
- 17 18 3376 3377 O
healing 18 25 3377 3384 O
wound 26 31 3385 3390 O
, 31 32 3390 3391 O
non 33 36 3392 3395 O
- 36 37 3395 3396 O
healing 37 44 3396 3403 O
ulcer 45 50 3404 3409 O
, 50 51 3409 3410 O
or 52 54 3411 3413 O
benign 55 61 3414 3420 O
bone 62 66 3421 3425 O
fracture 67 75 3426 3434 O
( 76 77 3435 3436 O
patients 77 85 3436 3444 O
with 86 90 3445 3449 O
stress 91 97 3450 3456 O
insufficiency 98 111 3457 3470 O
fractures 112 121 3471 3480 O
e.g. 122 126 3481 3485 O
from 127 131 3486 3490 O
osteoporosis 132 144 3491 3503 B-chronic_disease
or 145 147 3504 3506 O
pathological 148 160 3507 3519 B-chronic_disease
fracture 161 169 3520 3528 I-chronic_disease
from 170 174 3529 3533 O
tumor 175 180 3534 3539 B-cancer
are 181 184 3540 3543 O
eligible 185 193 3544 3552 O
for 194 197 3553 3556 O
study 198 203 3557 3562 O
) 203 204 3562 3563 O

Previous 0 8 3564 3572 O
assignment 9 19 3573 3583 O
to 20 22 3584 3586 O
treatment 23 32 3587 3596 B-treatment
during 33 39 3597 3603 O
this 40 44 3604 3608 O
study 45 50 3609 3614 O

Prior 0 5 3615 3620 B-treatment
systemic 6 14 3621 3629 I-treatment
therapy 15 22 3630 3637 I-treatment
with 23 27 3638 3642 O
a 28 29 3643 3644 O
small 30 35 3645 3650 O
molecule 36 44 3651 3659 O
oral 45 49 3660 3664 B-treatment
kinase 50 56 3665 3671 I-treatment
inhibitor 57 66 3672 3681 I-treatment
, 66 67 3681 3682 O
including 68 77 3683 3692 O
but 78 81 3693 3696 O
not 82 85 3697 3700 O
limited 86 93 3701 3708 O
to 94 96 3709 3711 O
: 96 97 3711 3712 O
pazopanib 98 107 3713 3722 B-treatment
, 107 108 3722 3723 O
sunitinib 109 118 3724 3733 B-treatment
, 118 119 3733 3734 O
sorafenib 120 129 3735 3744 B-treatment
, 129 130 3744 3745 O
everolimus 131 141 3746 3756 B-treatment
, 141 142 3756 3757 O
sirolimus 143 152 3758 3767 B-treatment
, 152 153 3767 3768 O
vemurafenib 154 165 3769 3780 B-treatment
, 165 166 3780 3781 O
dasatinib 167 176 3782 3791 B-treatment
and 177 180 3792 3795 O
trametinib 181 191 3796 3806 B-treatment

Proteinuria 0 11 3807 3818 B-clinical_variable
> 12 13 3819 3820 O
100 14 17 3821 3824 B-lower_bound
mg 18 20 3825 3827 I-lower_bound
/ 20 21 3827 3828 I-lower_bound
dl 21 23 3828 3830 I-lower_bound
on 24 26 3831 3833 O
urine 27 32 3834 3839 O
analysis 33 41 3840 3848 O

Subject 0 7 3849 3856 O
must 8 12 3857 3861 O
be 13 15 3862 3864 O
able 16 20 3865 3869 O
to 21 23 3870 3872 O
swallow 24 31 3873 3880 O
and 32 35 3881 3884 O
retain 36 42 3885 3891 O
oral 43 47 3892 3896 B-treatment
medication 48 58 3897 3907 I-treatment

Subjects 0 8 3908 3916 O
with 9 13 3917 3921 O
thrombotic 14 24 3922 3932 O
, 24 25 3932 3933 O
embolic 26 33 3934 3941 O
, 33 34 3941 3942 O
venous 35 41 3943 3949 O
, 41 42 3949 3950 O
or 43 45 3951 3953 O
arterial 46 54 3954 3962 O
events 55 61 3963 3969 O
, 61 62 3969 3970 O
such 63 67 3971 3975 O
as 68 70 3976 3978 O
cerebrovascular 71 86 3979 3994 B-chronic_disease
accident 87 95 3995 4003 I-chronic_disease
( 96 97 4004 4005 O
including 97 106 4005 4014 O
transient 107 116 4015 4024 B-chronic_disease
ischemic 117 125 4025 4033 I-chronic_disease
attacks 126 133 4034 4041 I-chronic_disease
) 133 134 4041 4042 O
deep 135 139 4043 4047 B-chronic_disease
vein 140 144 4048 4052 I-chronic_disease
thrombosis 145 155 4053 4063 I-chronic_disease
or 156 158 4064 4066 O
pulmonary 159 168 4067 4076 B-chronic_disease
embolism 169 177 4077 4085 I-chronic_disease
within 178 184 4086 4092 O
6 185 186 4093 4094 B-upper_bound
months 187 193 4095 4101 I-upper_bound
of 194 196 4102 4104 O
start 197 202 4105 4110 O
of 203 205 4111 4113 O
study 206 211 4114 4119 B-treatment
treatment 212 221 4120 4129 I-treatment

Substance 0 9 4130 4139 O
abuse 10 15 4140 4145 O
, 15 16 4145 4146 O
medical 17 24 4147 4154 O
, 24 25 4154 4155 O
psychological 26 39 4156 4169 B-chronic_disease
or 40 42 4170 4172 O
social 43 49 4173 4179 B-chronic_disease
conditions 50 60 4180 4190 I-chronic_disease
that 61 65 4191 4195 O
may 66 69 4196 4199 O
interfere 70 79 4200 4209 O
with 80 84 4210 4214 O
the 85 88 4215 4218 O
subject 89 96 4219 4226 O
's 96 98 4226 4228 O
participation 99 112 4229 4242 O
in 113 115 4243 4245 O
the 116 119 4246 4249 O
study 120 125 4250 4255 O
or 126 128 4256 4258 O
evaluation 129 139 4259 4269 O
of 140 142 4270 4272 O
the 143 146 4273 4276 O
study 147 152 4277 4282 O
results 153 160 4283 4290 O

Uncontrolled 0 12 4291 4303 O
hypertension 13 25 4304 4316 B-chronic_disease
( 26 27 4317 4318 O
systolic 27 35 4318 4326 B-clinical_variable
pressure 36 44 4327 4335 I-clinical_variable
> 45 46 4336 4337 O
140 46 49 4337 4340 B-lower_bound
mm 50 52 4341 4343 I-lower_bound
Hg 53 55 4344 4346 I-lower_bound
or 56 58 4347 4349 O
diastolic 59 68 4350 4359 B-clinical_variable
pressure 69 77 4360 4368 I-clinical_variable
> 78 79 4369 4370 O
90 80 82 4371 4373 B-lower_bound
mm 83 85 4374 4376 I-lower_bound
Hg 86 88 4377 4379 I-lower_bound
[ 89 90 4380 4381 O
NCI 90 93 4381 4384 O
- 93 94 4384 4385 O
CTCAE 94 99 4385 4390 O
v 100 101 4391 4392 O
4.0 102 105 4393 4396 O
] 105 106 4396 4397 O
on 107 109 4398 4400 O
repeated 110 118 4401 4409 O
measurement 119 130 4410 4421 O
) 130 131 4421 4422 O
despite 132 139 4423 4430 O
optimal 140 147 4431 4438 O
medical 148 155 4439 4446 O
management 156 166 4447 4457 O

Use 0 3 4458 4461 O
of 4 6 4462 4464 O
any 7 10 4465 4468 O
herbal 11 17 4469 4475 B-treatment
remedy 18 24 4476 4482 I-treatment
( 25 26 4483 4484 O
e.g. 26 30 4484 4488 O
St. 31 34 4489 4492 B-treatment
John 35 39 4493 4497 I-treatment
wort 40 44 4498 4502 I-treatment
[ 45 46 4503 4504 I-treatment
Hypericum 46 55 4504 4513 I-treatment
perforatum 56 66 4514 4524 I-treatment
] 66 67 4524 4525 I-treatment
) 67 68 4525 4526 O

WHO 0 3 4527 4530 B-clinical_variable
Performance 4 15 4531 4542 I-clinical_variable
Status 16 22 4543 4549 I-clinical_variable
0 23 24 4550 4551 B-lower_bound
, 24 25 4551 4552 O
1 26 27 4553 4554 O
or 28 30 4555 4557 O
2 31 32 4558 4559 B-upper_bound

Weight 0 6 4560 4566 B-clinical_variable
≥ 7 8 4567 4568 O
15 9 11 4569 4571 B-lower_bound
kg 12 14 4572 4574 I-lower_bound
( 15 16 4575 4576 I-lower_bound
33 16 18 4576 4578 I-lower_bound
lb 19 21 4579 4581 I-lower_bound
) 21 22 4581 4582 I-lower_bound

Women 0 5 4583 4588 B-gender
who 6 9 4589 4592 O
are 10 13 4593 4596 O
pregnant 14 22 4597 4605 B-pregnancy

new 0 3 4606 4609 O
disease 4 11 4610 4617 O
sites 12 17 4618 4623 O
or 18 20 4624 4626 O
20 21 23 4627 4629 O
% 23 24 4629 4630 O
growth 25 31 4631 4637 O
of 32 34 4638 4640 O
index 35 40 4641 4646 B-clinical_variable
lesions 41 48 4647 4654 I-clinical_variable
) 48 49 4654 4655 O
within 50 56 4656 4662 O
6 57 58 4663 4664 B-upper_bound
months 59 65 4665 4671 I-upper_bound
of 66 68 4672 4674 O
registration 69 81 4675 4687 O

prior 0 5 4688 4693 B-treatment
investigational 6 21 4694 4709 I-treatment
therapy 22 29 4710 4717 I-treatment
may 30 33 4718 4721 O
not 34 37 4722 4725 O
have 38 42 4726 4730 O
been 43 47 4731 4735 O
given 48 53 4736 4741 O
< 54 55 4742 4743 O
5 56 57 4744 4745 B-upper_bound
half 58 62 4746 4750 O
- 62 63 4750 4751 O
lives 63 68 4751 4756 O
of 69 71 4757 4759 O
last 72 76 4760 4764 O
dose 77 81 4765 4769 O
of 82 84 4770 4772 O
treatment 85 94 4773 4782 B-treatment
, 94 95 4782 4783 O
or 96 98 4784 4786 O
< 99 100 4787 4788 O
14 101 103 4789 4791 B-upper_bound
days 104 108 4792 4796 I-upper_bound
, 108 109 4796 4797 O
whichever 110 119 4798 4807 O
is 120 122 4808 4810 O
greater 123 130 4811 4818 O

≥ 0 1 4819 4820 O
NCI 2 5 4821 4824 O
- 5 6 4824 4825 O
CTCAE 6 11 4825 4830 O
version 12 19 4831 4838 O
4.03 20 24 4839 4843 O
Grade 25 30 4844 4849 B-lower_bound
2 31 32 4850 4851 I-lower_bound
dyspnea 33 40 4852 4859 B-clinical_variable

